Vijay Patil

4.2k total citations
215 papers, 1.6k citations indexed

About

Vijay Patil is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Vijay Patil has authored 215 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pulmonary and Respiratory Medicine, 105 papers in Oncology and 75 papers in Otorhinolaryngology. Recurrent topics in Vijay Patil's work include Head and Neck Cancer Studies (75 papers), Lung Cancer Treatments and Mutations (70 papers) and Lung Cancer Research Studies (41 papers). Vijay Patil is often cited by papers focused on Head and Neck Cancer Studies (75 papers), Lung Cancer Treatments and Mutations (70 papers) and Lung Cancer Research Studies (41 papers). Vijay Patil collaborates with scholars based in India, United Kingdom and United States. Vijay Patil's co-authors include Kumar Prabhash, Vanita Noronha, Amit Joshi, Atanu Bhattacharjee, Amit Joshi, Abhishek Mahajan, Sachin Dhumal, Nandini Menon, Pankaj Chaturvedi and Anuradha Chougule and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vijay Patil

185 papers receiving 1.6k citations

Peers

Vijay Patil
Sungjin Kim United States
Jie Su Canada
D. Ian Hodson Canada
Shrujal S. Baxi United States
Salvatore Alfieri Italy
Daniela Musio Italy
Cheng Xu China
Gustavo Nader Marta Brazil
Cees A. Meeuwis Netherlands
Sungjin Kim United States
Vijay Patil
Citations per year, relative to Vijay Patil Vijay Patil (= 1×) peers Sungjin Kim

Countries citing papers authored by Vijay Patil

Since Specialization
Citations

This map shows the geographic impact of Vijay Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay Patil more than expected).

Fields of papers citing papers by Vijay Patil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijay Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay Patil. The network helps show where Vijay Patil may publish in the future.

Co-authorship network of co-authors of Vijay Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Vijay Patil. A scholar is included among the top collaborators of Vijay Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay Patil. Vijay Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patil, Vijay, et al.. (2025). Promising Flavone Derivatives as Anticancer Agents. Medicinal Chemistry. 21. 1 indexed citations
2.
Kumar, Amit, Akhil Kapoor, Vanita Noronha, et al.. (2024). Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settings. PubMed. 2(1). 35–35. 1 indexed citations
3.
Bajpai, Jyoti, Gaurav Gupta, Bharat Rekhi, et al.. (2024). Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India. JCO Global Oncology. 10(10). e2300308–e2300308.
4.
Noronha, Vanita, et al.. (2024). Retrospective analysis: Does 5-FU dose adjustment per DPYD mutation status affect toxicity?. Journal of Clinical Oncology. 42(16_suppl). 11172–11172.
5.
Noronha, Vanita, et al.. (2024). Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 94(5). 659–668. 2 indexed citations
6.
Noronha, Vanita, Srikanth S. Manda, Rohit Mishra, et al.. (2023). Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy. Gene. 893. 147952–147952. 4 indexed citations
7.
Dhumal, Sachin, Vijay Patil, Vanita Noronha, et al.. (2023). Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer. The Lancet Regional Health - Southeast Asia. 12. 100143–100143. 2 indexed citations
8.
Noronha, Vanita, Omshree Shetty, Asawari Patil, et al.. (2021). FGFR alterations in head-and-neck cancer. Cancer Research Statistics and Treatment. 4(4). 737–746. 3 indexed citations
9.
Chaukar, Devendra, Vijay Patil, Shivakumar Thiagarajan, et al.. (2021). Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer. Journal of Clinical Oncology. 40(3). 272–281. 37 indexed citations
10.
11.
Joshi, Amit, et al.. (2021). Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy. Therapeutic Advances in Drug Safety. 12. 586533232–586533232. 2 indexed citations
12.
13.
Kalra, D., Gunjesh Kumar Singh, Nandini Menon, et al.. (2020). 393P Financial toxicity in patients undergoing systemic therapy in brain tumours: A cross-sectional study. Annals of Oncology. 31. S407–S408.
14.
Noronha, Vanita, Gunjesh Kumar Singh, Vijay Patil, et al.. (2020). 280P Safety and efficacy of concurrent chemoradiotherapy for head and neck cancers in younger versus older patients: Post hoc analysis of a randomized control trial. Annals of Oncology. 31. S1351–S1351. 1 indexed citations
15.
Joshi, Amit, et al.. (2019). Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. SHILAP Revista de lepidopterología. 22 indexed citations
16.
Thiagarajan, Shivakumar, Harsh Dhar, Atanu Bhattacharjee, et al.. (2019). Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncology. 100. 104455–104455. 8 indexed citations
17.
Mahajan, Abhishek, et al.. (2018). 72PD MR imaging radiomics of NSCLC brain metastases: A potential targetable imaging biomarker for EGFR status. Journal of Thoracic Oncology. 13(4). S39–S40. 2 indexed citations
18.
19.
Ramaswamy, Anant, Amit Joshi, Vanita Noronha, et al.. (2016). Patterns of Care and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma—Results From a Tertiary Cancer Center in India. Clinical Genitourinary Cancer. 15(3). e345–e355. 9 indexed citations
20.
Joshi, Amit, Nidhi Tandon, Vanita Noronha, et al.. (2015). Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal. Indian Journal of Medical and Paediatric Oncology. 36(3). 172–175. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sungjin Kim Breakdown of academic impact, for papers by Jie Su Breakdown of academic impact, for papers by D. Ian Hodson Breakdown of academic impact, for papers by Shrujal S. Baxi Breakdown of academic impact, for papers by Salvatore Alfieri Breakdown of academic impact, for papers by Daniela Musio Breakdown of academic impact, for papers by Cheng Xu Breakdown of academic impact, for papers by Gustavo Nader Marta Breakdown of academic impact, for papers by Cees A. Meeuwis
Rankless by CCL
2026